Ophidion Inc.

Pasadena, CA

UEI
NNGSPLRM7DL6
CAGE
52AQ7
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
2265 E Foothill Blvd, Pasadena, CA 91107, USA
Website
ophidion.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of A5 nicotinic receptor agonists for smoking cessation R44DA032464 National Institute on Drug Abuse (NIH) $793,191
In vivo and in vitro tools to target CHRNA5 for smoking cessation. R41DA032464 National Institutes of Health $296,028
Sirna mediated modulation of LYNX1 for cognitive enhancement R43MH094004 National Institutes of Health $656,365
Improved cell line and assay development of nicotinic receptor complexes for HTS R43MH083416 National Institutes of Health $500,000

Quick answers

Is Ophidion Inc. registered in SAM.gov?

Yes. Ophidion Inc.'s SAM.gov registration is active through May 24, 2027.

What is Ophidion Inc.'s most recent federal award?

Ophidion Inc.'s most recent federal grant award is Development of A5 nicotinic receptor agonists for smoking cessation (R44DA032464), from National Institute on Drug Abuse (NIH), on September 1, 2011.

On GovTribe

See Ophidion Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login